Medtech sits on the sidelines as ACA repeal looms

Some major medical device industry lobbying groups are staying mum for now about the expected repeal of the U.S. Affordable Care Act—even though an extensive overhaul of the national healthcare system would have a serious impact on medtech.

With so much unpredictability around how the incoming Trump administration and the new Republican Congress will replace the ACA, the industry’s representatives have been taking more of a wait and see approach.

“Keep your powder dry,” Greg Crist, executive vice president of public affairs at AdvaMed, says of the approach. AdvaMed for now has a laser-like focus on quickly achieving a major policy goal: permanent repeal of the 2.3% medical device excise tax that was part of the ACA.

Get the full story on our sister site, Medical Design & Outsourcing.

Create your own user feedback survey

The post Medtech sits on the sidelines as ACA repeal looms appeared first on MassDevice.